Free
CNBC

Eli Lilly CEO, Off The Charts, & Lessons Learned In Biotech

Listen in app
The Dow closed up 31 points hitting another all-time high and Cramer’s digging into today’s biggest movers. Then, the drug companies have been caught in political crosshairs, and Cramer’s getting to the core of it with Eli Lilly’s CEO. And, with the market at all-time highs, are there any bargains out there? Cramer’s going off the charts to look at bargain buys during market highs. And you’ve called in and stumped Professor Cramer, and tonight he’s turning in his homework on Wave Life Sciences and sharing what lessons he has learned through his research into speculative biotech names.
Learn more about your ad choices. Visit megaphone.fm/adchoices
0:45:07
Publication year
2019
Have you already read it? How did you like it?
👍👎
fb2epub
Drag & drop your files (not more than 5 at once)